Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Codex DNA Inc.

    NASDAQ: DNAY · Real-Time Price · USD
    1.30
    0.10 (8.33%)
    At close: Jan 04, 2023, 6:00 AM

    Codex DNA Statistics

    Share Statistics

    Codex DNA has 29.48M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 29.48M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 7.53M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 79.75K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 79.75K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 0.93%

    Short Ratio (days to cover)

    n/a
    		 1.45

    Valuation Ratios

    The PE ratio is -0.73 and the forward PE ratio is null. Codex DNA's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -0.73

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 1.29

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.76

    P/FCF Ratio

    n/a
    		 -0.82

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Codex DNA.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.46.

    Current Ratio

    n/a
    		 4.08

    Quick Ratio

    n/a
    		 3.92

    Debt / Equity

    n/a
    		 0.46

    Debt / EBITDA

    n/a
    		 -0.46

    Debt / FCF

    n/a
    		 -0.5

    Interest Coverage

    n/a
    		 40.85

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $129,410.38

    Profits Per Employee

    n/a
    		 $-228,410.38

    Employee Count

    n/a
    		 212

    Asset Turnover

    n/a
    		 0.34

    Inventory Turnover

    n/a
    		 5.38

    Taxes

    Income Tax

    n/a
    		 -24K

    Effective Tax Rate

    n/a
    		 0.05%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0, so Codex DNA's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 1.44

    200-Day Moving Average

    n/a
    		 2.61

    Relative Strength Index (RSI)

    n/a
    		 51.01

    Average Volume (20 Days)

    n/a
    		 79,397

    Income Statement

    In the last 12 months, Codex DNA had revenue of 27.43M and earned -48.42M in profits. Earnings per share was -1.64.

    Revenue

    n/a
    		 27.43M

    Gross Profit

    n/a
    		 15.6M

    Operating Income

    n/a
    		 -49.71M

    Net Income

    n/a
    		 -48.42M

    EBITDA

    n/a
    		 -46.48M

    EBIT

    n/a
    		 -46.44M

    Earnings Per Share (EPS)

    n/a
    		 -1.64
    Full Income Statement

    Balance Sheet

    The company has 30.42M in cash and 21.43M in debt, giving a net cash position of 8.99M.

    Cash & Cash Equivalents

    n/a
    		 30.42M

    Total Debt

    n/a
    		 21.43M

    Net Cash

    n/a
    		 8.99M

    Retained Earnings

    n/a
    		 -113.74M

    Total Assets

    n/a
    		 24.74M

    Working Capital

    n/a
    		 1.49M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -38.72M and capital expenditures -4.47M, giving a free cash flow of -43.18M.

    Operating Cash Flow

    n/a
    		 -38.72M

    Capital Expenditures

    n/a
    		 -4.47M

    Free Cash Flow

    n/a
    		 -43.18M

    FCF Per Share

    n/a
    		 -1.47
    Full Cash Flow Statement

    Margins

    Gross margin is 56.84%, with operating and profit margins of -181.2% and -176.5%.

    Gross Margin

    n/a
    		 56.84%

    Operating Margin

    n/a
    		 -181.2%

    Pretax Margin

    n/a
    		 -176.59%

    Profit Margin

    n/a
    		 -176.5%

    EBITDA Margin

    n/a
    		 -169.44%

    EBIT Margin

    n/a
    		 -181.2%

    FCF Margin

    n/a
    		 -157.4%

    Dividends & Yields

    DNAY does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for DNAY.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -13.53

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist